Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-13-000217
Filing Date
2013-02-11
Accepted
2013-02-11 11:07:00
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 368109
2 ex31-1.htm EX-31.1 17482
3 ex31-2.htm EX-31.2 18077
4 ex32-1.htm EX-32.1 5915
  Complete submission text file 0001493152-13-000217.txt   2403168

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE vnth-20121231.xml EX-101.INS 208322
6 XBRL SCHEMA FILE vnth-20121231.xsd EX-101.SCH 30556
7 XBRL CALCULATION FILE vnth-20121231_cal.xml EX-101.CAL 44148
8 XBRL DEFINITION FILE vnth-20121231_def.xml EX-101.DEF 61915
9 XBRL LABEL FILE vnth-20121231_lab.xml EX-101.LAB 199342
10 XBRL PRESENTATION FILE vnth-20121231_pre.xml EX-101.PRE 142141
Mailing Address 11400 OLYMPIC BLVD., SUITE 640 LOS ANGELES CA 90064
Business Address 11400 OLYMPIC BLVD., SUITE 640 LOS ANGELES CA 90064 310-477-5811
Vantage Health (Filer) CIK: 0001497130 (see all company filings)

EIN.: 980659770 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-168930 | Film No.: 13589653
SIC: 2834 Pharmaceutical Preparations